Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

SuperGen Presentations at AACR-NCI-EORTC

DUBLIN, Calif. - 
      SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the 
      discovery and development of novel cancer therapies, today announced the 
      acceptance of seven abstracts for poster presentations on November 16, 
      17 and 18, 2009 at the 2009 AACR-NCI-EORTC Molecular Target
Posted : Mon, 09 Nov 2009 11:02:00 GMT
Author : SuperGen, Inc.
Category : Press Release
News Alerts by Email ( click here )
Press Release News | Home
DUBLIN, Calif. - (Business Wire) SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of seven abstracts for poster presentations on November 16, 17 and 18, 2009 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference in Boston, MA.

SuperGen’s presentations will review clinical and non-clinical advances in the following compounds: MP-470, SGI-1776, SGI-110, SGI-1252, as well as two presentations on the Etk program. The posters will be made available for viewing on the company’s website www.supergen.com following the respective presentations.

MP-470: The tyrosine kinase inhibitor MP470 inhibits RAD51-mediated homologous recombination and increases tumor cell radio- and chemosensitivity

Abstract A122, Monday Nov 16, 12:30 – 2:30 pm EST
 

SGI-110: In vivo activity of SGI-110, a novel hypomethylating agent for treatment in hematology and solid malignancies

Abstract A190, Monday Nov 16, 12:30 – 2:30 pm EST
 

MP-470: A self-emulsifying lipid suspension formulation enhances oral bioavailability of MP-470 in a randomized two-way crossover study in healthy male subjects

Abstract B209, Tuesday Nov 17, 12:30 – 2:30 pm EST
 

SGI-1776: The novel PIM kinase inhibitor SGI-1776 significantly enhances the preclinical activity of sunitinib in renal cell carcinoma

Abstract B272, Tuesday Nov 17, 12:30 – 2:30 pm EST

 

ETK/BMX: Mechanistic, functional and in vivo efficacy of inhibiting ETK/BMX in cancer models

Abstract B263, Tuesday Nov 17, 12:30 – 2:30 pm EST
 

SGI-1252: In vivo activity of SGI-1252, a potent, small-molecule dual inhibitor of JAK2 and ALK2

Abstract C206, Wednesday Nov 18, 12:30 – 2:30 pm EST
 

ETK: Development of potent, small-molecule inhibitors of ETK

Abstract C199 Wednesday Nov 18, 12:30 – 2:30 pm EST

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.

SuperGen, Inc.
Timothy L. Enns, 925-560-2810
Senior Vice President
Corporate Communications & Business Development
tenns@supergen.com
Susanna Chau, 925-560-2845
Manager
Investor Relations
schau@supergen.com


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark



Related News

Sennheiser USA Selects Hummingbird Media as Agency of Record for Consumer Electronics Line
OLD LYME, CT -- 11/23/09 -- Premium audio products manufacturer Sennheiser announced that NY-based Hummingbird Media, Inc. has been selected to drive the Company's U.S.-based PR initiatives in the consumer electronics market. The announce..

Callon Petroleum Company Announces Expiration and Results of Private Exchange Offer For 9.75% Senior Notes Due 2010
NATCHEZ, Miss. - Callon Petroleum Company (NYSE: CPE), announced today the expiration and results of its offer to exchange any and all of its outstanding 9.75% Senior Notes due 2010 (the “Senior Notes”). The exchange offer, which was originally scheduled to expire o

Complete Line of Non-Metallic Fiberglass Enclosures is Now Available from Solutions Direct
Online Distributor Offers Full-Line of Allied Moulded's NEMA 4X Fiberglass Enclosures/I/P PRiverside, CA (PRWEB) November 23, 2009 -- Allied Moulded's extensive line of NEMA fiberglass enclosures for indoor and outdoor use with sizes ranging from small 6" x 6" x 4" enclos...

Fitch Affirms AMD's IDR at 'B-'; Revises Outlook to Positive
CHICAGO & NEW YORK - Fitch Ratings has taken the following rating actions on Advanced Micro Devices Inc. (NYSE: AMD): --Long-term Issuer Default Rating (IDR) affirmed at 'B-'; --Senior unsecured debt upgraded to 'B-/RR4' from 'CC/RR6'.

Shrinking Inventory, Extended Federal Tax Credit Drive Santa Clara County Housing Market
SAN JOSE, Calif., Nov. 23 /PRNewswire/ -- Fewer new listings, more closed sales, and dramatically decreased inventory - that's how the Santa Clara County housing market is moving from where it was a year ago. According to MLSListings data, the October inventory stood ...

Forstall Art Center Presents the 4th Annual Art Jamboree and Sale, October 23 and 24
Birmingham, Alabama's a href= http://www.forstallartcenter.com onclick= linkClick( this.href ); target= _blank title= Forstall Art Center Forstall Art Center/a presents the 4th annual Art Jamboree, featuring up to 70% off retail, door prizes, free samples and free classroom demos./I...

Although in its Nascent Stage, The Future of Virtualization Market in India Looks Promising, Notes Frost & Sullivan
MUMBAI, India, Nov. 23 /PRNewswire/ -- Virtualization has long been portrayed as a technology that would change the dynamics of enterprise infrastructure. The overall market for virtualization in India is still nascent. It is shaping up to be one of the major trends that is expected...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.